A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable?

J Neurol. 2020 May;267(5):1464-1475. doi: 10.1007/s00415-020-09720-8. Epub 2020 Feb 1.

Abstract

Background: Numerous cross-sectional studies report cognitive impairment in multiple sclerosis (MS), but longitudinal studies with sufficiently long-term follow-up are scarce.

Objective: We aimed to investigate the cognitive 10-year course of a cohort of MS patients.

Methods: 59 patients with clinically isolated syndrome (CIS) or relapsing-remitting (RR) MS were evaluated with Rao's Brief Repeatable Battery of Neuropsychological Tests at baseline and follow-up (at least 10 years later). They constituted 47.2% of 124 consecutive CIS and RRMS patients originally evaluated at baseline. Patients assessed at follow-up were well matched for baseline clinical characteristics with dropouts.

Results: The proportion of MS patients with overall cognitive impairment was increased by 10% within the 10-year period. When grouped on the basis of impairment in specific cognitive domains at baseline, patients originally impaired showed improvement at follow-up, while the opposite trend was observed for patients non-impaired at first assessment. A detailed case-by-case investigation revealed mixed evolution patterns, several patients fail in fewer domains at follow-up compared to baseline or failing at different domains at follow-up compared to baseline.

Conclusions: This study suggests a more fluid picture for the evolution of cognitive function in a subgroup of MS patients and contradicts the concept of an inevitable, progressively evolving "dementia".

Keywords: CIS; Cognitive impairment; Longitudinal study; Multiple sclerosis; RRMS.

MeSH terms

  • Adult
  • Cognitive Dysfunction / etiology*
  • Cognitive Dysfunction / physiopathology*
  • Disease Progression*
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / complications*
  • Multiple Sclerosis, Relapsing-Remitting / physiopathology*
  • Neuropsychological Tests